Stay updated on B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.

Latest updates to the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check20 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check63 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check70 days agoChange DetectedThe web page has undergone significant changes in the description of a clinical study involving B-701 (vofatamab) and pembrolizumab, with key details about the study's phases and inclusion/exclusion criteria being removed. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference19%
- Check85 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.